Physician profile
Julia Matera
NPI 1104448588
$6,666.56
in general payments reported to CMS, 2019-2025
5 companies · $6,667 in 2025
The $6,667 reported for 2025 was more than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $6,667.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $2,500 · Travel and Lodging: $2,292 · Food and Beverage: $1,875.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $2,500.00 |
| Travel and Lodging | $2,291.61 |
| Food and Beverage | $1,874.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $4,101.43 | 2025 | Journey II, Real Intelligence, Legion |
| Zimmer Biomet Holdings, INC. | $1,446.03 | 2025 | G7, Oxford, Arcos |
| Stryker Corporation | $914.37 | 2025 | Mako, Pangea, Anato |
| Linkbio Corp | $141.92 | 2025 | |
| Depuy Synthes Sales INC. | $62.81 | 2025 | Hammerlock |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Matera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.